Literature DB >> 19176220

Effects of injection of biogenic amines on expression of gill related ion transporter mRNA and alpha-subunit protein in Litopenaeus vannamei.

Hong-Yu Liu1, Lu-Qing Pan, De-Bin Zheng.   

Abstract

We used semi-quantitative reverse transcription and the polymerase chain reaction (RT-PCR) to identify and characterize the mRNA of Na(+)/K(+)-ATPase alpha-subunit and Vacuolar-type H/-ATPase (V-ATPase) beta-subunit prepared from gills of the white shrimp Litopenaeus vannamei. Western blot and immunocytochemistry analysis were employeed to investigate the effects of biogenic amines such as dopamine (DA) and 5-hydroxytryptamine (5-HT) injection on expression of protein abundance and immunostained sites. Our results show that the gill Na(+)/K(+)-ATPase of 5-HT treatments increased lag to those of DA treatments. However, the DA and 5-HT have no significant effects on the activity of V-ATPase. The biogenic amines could induce the synthesis of Na(+)/K(+)-ATPase alpha-subunit mRNA in the first 12 h. The degree of change in Na(+)/K(+)-ATPase alpha-subunit mRNA expression were different between DA and 5-HT treated groups which depend on the dose. The expression of V-ATPase beta-subunit mRNA was not markedly affected by the biogenic amines. Concomitant elevation of Na(+)/K(+)-ATPase activity, alpha-subunit mRNA as well as protein abundance in response to injected biogenic amines was also found in Na(+)/K(+)-ATPase immunostained sites within the gill epithelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176220     DOI: 10.1016/j.cbpa.2009.01.004

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  1 in total

1.  Effects of the recombinant crustacean hyperglycemic hormones rCHH-B1 and rCHH-B2 on the osmo-ionic regulation of the shrimp Litopenaeus vannamei exposed to acute salinity stress.

Authors:  Laura Camacho-Jiménez; Fernando Díaz; Edna Sánchez-Castrejón; Elizabeth Ponce-Rivas
Journal:  J Comp Physiol B       Date:  2018-03-26       Impact factor: 2.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.